Jazz Pharma’s sleep disorder treatment gets FDA nod
(Reuters) – The U.S. Food and Drug Administration approved Jazz Pharmaceuticals Plc’s treatment for patients with a form of sleep…
Jazz Pharmaceuticals to settle U.S. probe for $57 million
BOSTON (Reuters) – Jazz Pharmaceuticals Plc said on Tuesday it had agreed to pay $57 million to resolve a U.S.…